ClinicalTrials.gov
ClinicalTrials.gov Menu

Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients (ERAMUNE-01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01019551
Recruitment Status : Completed
First Posted : November 25, 2009
Last Update Posted : June 13, 2013
Sponsor:
Collaborators:
Cytheris SA
Merck Sharp & Dohme Corp.
Pfizer
Information provided by (Responsible Party):
Objectif Recherche Vaccins SIDA

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2012
  Actual Study Completion Date : February 2013
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):